Abstract
Pharmacokinetics of 141W94 after multiple dosing in patients with HIV infection: A preliminary report: BM Sadler 1, C Rawls 1, J Millard 1, C Hanson 1, P Dowd 2, 160-002 Clinical Investigators. Glaxo Wellcome Research and Development, 1RTP, NC, USA and 2Beckenham, Kent, UK
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
